These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 34659499)
1. Effect of inner physical properties on powder adhesion in inhalation capsules in case of a high resistance device. Otake H; Minami M; Yamaguchi M; Akiyama S; Inaba K; Nagai N Exp Ther Med; 2021 Dec; 22(6):1353. PubMed ID: 34659499 [TBL] [Abstract][Full Text] [Related]
2. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend. Wauthoz N; Hennia I; Ecenarro S; Amighi K Int J Pharm; 2018 Dec; 553(1-2):47-56. PubMed ID: 30321640 [TBL] [Abstract][Full Text] [Related]
3. Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers. Shur J; Lee S; Adams W; Lionberger R; Tibbatts J; Price R AAPS J; 2012 Dec; 14(4):667-76. PubMed ID: 22723022 [TBL] [Abstract][Full Text] [Related]
4. Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types. Benke E; Varga P; Szabó-Révész P; Ambrus R Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34064698 [TBL] [Abstract][Full Text] [Related]
5. Investigation on the aerosol performance of dry powder inhalation hypromellose capsules with different lubricant levels. Saleem IY; Diez F; Jones BE; Kayali N; Polo L Int J Pharm; 2015 Aug; 492(1-2):258-63. PubMed ID: 26196275 [TBL] [Abstract][Full Text] [Related]
6. Correcting Photo Reflection Method Output and Its Application in the Dynamic Analysis of Particle Release from Dry Powder Inhalers. Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S J Aerosol Med Pulm Drug Deliv; 2021 Aug; 34(4):223-230. PubMed ID: 33147100 [No Abstract] [Full Text] [Related]
7. Understanding the motion of hard-shell capsules in dry powder inhalers. Benque B; Khinast JG Int J Pharm; 2019 Aug; 567():118481. PubMed ID: 31260784 [TBL] [Abstract][Full Text] [Related]
8. Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications. Behara SR; Farkas DR; Hindle M; Longest PW Pharm Res; 2014 Feb; 31(2):360-72. PubMed ID: 23949304 [TBL] [Abstract][Full Text] [Related]
9. Importance of powder residence time for the aerosol delivery performance of a commercial dry powder inhaler Aerolizer(®). Jiang L; Tang Y; Zhang H; Lu X; Chen X; Zhu J J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):265-79. PubMed ID: 22280548 [TBL] [Abstract][Full Text] [Related]
13. The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers. Abadelah M; Al-Assadi J; Rooney J; Larhrib H Saudi Pharm J; 2020 Jan; 28(1):74-86. PubMed ID: 31920434 [TBL] [Abstract][Full Text] [Related]
14. Impact of holding position during inhalation on drug release from a reservoir-, blister- and capsule-type dry powder inhaler. Kondo T; Tanigaki T; Yokoyama H; Hibino M; Tajiri S; Akazawa K; Yamada Y; Cassan SM J Asthma; 2017 Oct; 54(8):792-797. PubMed ID: 27929704 [TBL] [Abstract][Full Text] [Related]
15. A quantitative approach to predicting lung deposition profiles of pharmaceutical powder aerosols. Yaqoubi S; Chan HK; Nokhodchi A; Dastmalchi S; Alizadeh AA; Barzegar-Jalali M; Adibkia K; Hamishehkar H Int J Pharm; 2021 Jun; 602():120568. PubMed ID: 33812969 [TBL] [Abstract][Full Text] [Related]
16. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older. Komase Y; Asako A; Kobayashi A; Sharma R Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354 [TBL] [Abstract][Full Text] [Related]
17. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device. Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675 [TBL] [Abstract][Full Text] [Related]
18. Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder. Gauani H; Baker T; Li Z; Malinin VS; Perkins WR; Sullivan EJ; Cipolla D Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986795 [TBL] [Abstract][Full Text] [Related]
19. Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation. Faulhammer E; Zellnitz S; Wutscher T; Stranzinger S; Zimmer A; Paudel A Int J Pharm; 2018 Jan; 536(1):326-335. PubMed ID: 29217472 [TBL] [Abstract][Full Text] [Related]
20. "Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs. Martinelli F; Balducci AG; Rossi A; Sonvico F; Colombo P; Buttini F Int J Pharm; 2015 Jun; 487(1-2):197-204. PubMed ID: 25843756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]